The IKK-related kinases: from innate immunity to oncogenesis

被引:160
作者
Clement, Jean-Francois [1 ,2 ]
Meloche, Sylvain [3 ,4 ,5 ]
Servant, Marc J. [1 ,2 ]
机构
[1] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada
[2] Univ Montreal, Grp Rech Univ Medicament, Montreal, PQ H3C 3J7, Canada
[3] Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3C 3J7, Canada
[4] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada
[5] Univ Montreal, Dept Mol Biol, Montreal, PQ H3C 3J7, Canada
基金
加拿大健康研究院;
关键词
cancer; IKKi; TBK1; cytokines; NF-kappa B; interferon regulatory factor; inflammation;
D O I
10.1038/cr.2008.273
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Over the past four years, the field of the innate immune response has been highly influenced by the discovery of the I kappa B kinase (IKK)-related kinases, TANK Binding Kinase 1 (TBK1) and IKKi, which regulate the activity of interferon regulatory factor (IRF)-3/IRF-7 and NF-kappa B transcription factors. More recently, additional essential components of the signaling pathways that activate these IKK homologues have been discovered. These include the RNA helicases RIGi and MDA5, and the downstream mitochondrial effector known as CARDIF/MAVS/VISA/IPS-1. In addition to their essential functions in controlling the innate immune response, recent studies have highlighted a role of these kinases in cell proliferation and oncogenesis. The canonical IKKs are well recognized to be a bridge linking chronic inflammation to cancer. New findings now suggest that the IKK-related kinases TBK1 and IKKi also participate in signaling pathways that impact on cell transformation and tumor progression. This review will therefore summarize and discuss the role of TBK1 and IKKi in cellular transformation and oncogenesis by focusing on their regulation and substrate specificity.
引用
收藏
页码:889 / 899
页数:11
相关论文
共 118 条
[1]   IKK-i/IKKε controls constitutive, cancer cell-associated NF-κB activity via regulation of Ser-536 p65/RelA phosphorylation [J].
Adli, Mazhar ;
Baldwin, Albert S. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (37) :26976-26984
[2]   SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production [J].
An, Huazhang ;
Zhao, Wei ;
Hou, Jin ;
Zhang, Yan ;
Xie, Yun ;
Zheng, Yuejuan ;
Xu, Hongmei ;
Qian, Cheng ;
Zhou, Jun ;
Yu, Yizhi ;
Liu, Shuxun ;
Feng, Gensheng ;
Cao, Xuetao .
IMMUNITY, 2006, 25 (06) :919-928
[3]   Oncogenic Ras-induced expression of cytokines: A new target of anti-cancer therapeutics [J].
Ancrile, Brooke B. ;
O'Hayer, Kevin M. ;
Counter, Christopher M. .
MOLECULAR INTERVENTIONS, 2008, 8 (01) :22-27
[4]   The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-β promoter [J].
Andrejeva, J ;
Childs, KS ;
Young, DF ;
Carlos, TS ;
Stock, N ;
Goodbourn, S ;
Randall, RE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (49) :17264-17269
[5]   A FADD-dependent innate immune mechanism in mammalian cells [J].
Balachandran, S ;
Thomas, E ;
Barber, GN .
NATURE, 2004, 432 (7015) :401-405
[6]   Oncolytic activity of vesicular stomatitis virus is effective against tumors exhibiting aberrant p53, Ras, or Myc function and involves the induction of apoptosis [J].
Balachandran, S ;
Porosnicu, M ;
Barber, GN .
JOURNAL OF VIROLOGY, 2001, 75 (07) :3474-3479
[7]   Vesicular stomatitis virus (VSV) therapy of tumors [J].
Balachandran, S ;
Barber, GN .
IUBMB LIFE, 2000, 50 (02) :135-138
[8]   Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[9]  
Barnes BJ, 2003, CANCER RES, V63, P6424
[10]   Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes [J].
Barnes, BJ ;
Kellum, MJ ;
Field, AE ;
Pitha, PM .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (16) :5721-5740